FOXO3 and hepatocellular carcinoma: As a multifunctional transcription factor, FOXO3a has been widely studied and its expression was found to be reduced in various types of solid cancers, such as breast cancer [16], nasopharyngeal carcinoma [19], ovarian cancer [18], gastric cancer [17] and hepatocellular carcinoma [20].